An improved preparation of Atorvastatin

Details for Australian Patent Application No. 2005221733 (hide)

Owner Apotex Pharmachem Inc.

Inventors Zhao, Yajun; Wang, Fan; Murthy, Keshava K.S.; Horne, Stephen E.; Guntoori, Bhaskar Reddy; Che, Daqing

Agent Shelston IP

Pub. Number AU-B-2005221733

PCT Pub. Number WO2005/087723

Priority 2,460,935 15.03.04 CA

Filing date 11 March 2005

Wipo publication date 22 September 2005

Acceptance publication date 17 March 2011

International Classifications

C07D 207/34 (2006.01) Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 207/416 (2006.01) Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

Event Publications

5 October 2006 PCT application entered the National Phase

  PCT publication WO2005/087723 Priority application(s): WO2005/087723

17 March 2011 Application Accepted

  Published as AU-B-2005221733

6 October 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). This application has been accepted or advertised accepted. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005221734-Thiol methyltransferase-based selection

2005221729-Infectious aetiology of prostatic disease and methods to identify causative agents